Executive function deficits and emotional dysregulation are challenging aspects of ADHD for many adults and are not always adequately addressed by current treatments,” said Dr. Lenard A. Adler, ...

Thalapathy Vijay surprised many with a Mumbai visit for director Atlee's wife Priya's baby shower, showcasing their strong bond beyond cinema. Amidst 'Jana Nayagan' release uncertainties, Vijay's ...

Electroacupuncture Promotes Neural Repair by Inhibiting Calcium-Driven ER Stress After Spinal Cord Injury. Schematic illustration of the proposed mechanism by which electroacupuncture at the Shenshu ...

A thoughtful exploration of how disability impacts intimacy, relationships, and bodily functions, highlighting challenges, adaptations, and personal stories. Jimmy Kimmel announces change out of ...

Albert Ludolph, MD, lead author and Senior Professor of Neurology at the University of Ulm, stated: "Our findings highlight the importance of early intervention in ALS with masitinib, demonstrating ...

AB SCIENCE ANNOUNCES NEW PUBLICATION ON MEDRXIV HIGHLIGHTING CLINICAL BENEFIT WITH MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS PATIENTS PRIOR ANY COMPLETE LOSS OF FUNCTION Significant improvement in ...

Governor Santosh Kumar Gangwar graced Delhi Public School, Bokaro Steel City's annual function, emphasizing collective efforts for higher education and inspiring students as the nation's vital ...

From AI to Air, Siri to Slim — Apple has shifted focus from its trademark software to hardware innovation with the launch of its latest iPhone 17 and the iPhone Air series released worldwide, ...

Findings published in The American Journal of Pathology identify GLUD1 enzyme as a potential therapeutic target for muscle restoration through metabolic reprogramming, addressing clinically unmet need ...

iNKT cells uniquely remodel the tumor microenvironment, overcome immune resistance, and enable scalable off-the-shelf cell therapy NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc.

NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies, ...